Literature DB >> 1185163

Biochemical post-mortem findings in depressed patients.

W Birkmayer, P Riederer.   

Abstract

Biochemical human post-mortem studies on depressed patients indicate an unspecific deficiency of neurotransmitters in several brain areas. The loss of drive of these patients could be correlated with a decrease of striatal dopamine concentration. Noradrenaline was significantly diminished in red nucleus, a fact which points to the characteristic posture of depressed patients. Serotonin was diminished in all brain areas. During remission all values trended to be normal. There also exists a circadian disrhythm in depressed patients resulting in lowered VMA- and HVA-levels in urines during the morning and a remission to normal values in the evening. This agrees with the findings of lowered blood tyrosine levels in the morning. The ratio of blood tyrosine and tryptophan is disturbed during depression and recovers during remission. Central and peripheral biochemical mechanisms seems to be involved in depression syndrom.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1185163     DOI: 10.1007/bf01663627

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  21 in total

1.  METABOLISM OF (H3)NOREPINEPHRINE IN THE RAT BRAIN.

Authors:  J GLOWINSKI; I J KOPIN; J AXELROD
Journal:  J Neurochem       Date:  1965-01       Impact factor: 5.372

2.  On the presence of 3-hydroxytyramine in brain.

Authors:  A CARLSSON; M LINDQVIST; T MAGNUSSON; B WALDECK
Journal:  Science       Date:  1958-02-28       Impact factor: 47.728

3.  The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs.

Authors:  M VOGT
Journal:  J Physiol       Date:  1954-03-29       Impact factor: 5.182

4.  Serotonin content of some mammalian tissues and urine and a method for its determination.

Authors:  B M TWAROG; I H PAGE
Journal:  Am J Physiol       Date:  1953-10

5.  Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms.

Authors:  N E Andén; J Engel
Journal:  Adv Neurol       Date:  1974

6.  [Statistical aspects of the tyrosine-tryptophan diagram in depression (author's transl)].

Authors:  L Ambrozi; P Riederer; W Birkmayer; E Neumayer
Journal:  Dtsch Med Wochenschr       Date:  1974-05-17       Impact factor: 0.628

7.  The daily rhythm of HVA, VMA, (VA) and 5-HIAA in depression-syndrome.

Authors:  P Riederer; W Birkmayer; E Neumayer; L Ambrozi; W Linauer
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

8.  The balance of biogenic amines as condition for normal behaviour.

Authors:  W Birkmayer; W Danielczyk; E Neumayer; P Riederer
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

Review 9.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

10.  [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Wien Klin Wochenschr       Date:  1961-11-10       Impact factor: 1.704

View more
  9 in total

1.  On central effects of serotonin re-uptake inhibitors: quantitative EEG and psychometric studies with sertraline and zimelidine.

Authors:  B Saletu; J Grünberger; L Linzmayer
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

2.  Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis.

Authors:  P Riederer; S Wuketich
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

3.  Increased synaptic markers in hippocampus of depressed patients.

Authors:  O S Jørgensen; P Riederer
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

4.  Diurnal changes in dopamine-beta-hydroxylase, homovanillic acid and 3-methoxy-4-hydroxyphenylglycol in serum of man.

Authors:  E Markianos; H Backman
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

5.  Studies on brain metabolism of biogenic amines.

Authors:  U Schacht; M Leven; G Bäcker
Journal:  Br J Clin Pharmacol       Date:  1977       Impact factor: 4.335

6.  Distribution of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in human brain in relation to age, drug influence, agonal status and circadian variation.

Authors:  G Bucht; R Adolfsson; C G Gottfries; B E Roos; B Winblad
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

7.  Increased serum glutamate in depressed patients.

Authors:  J S Kim; W Schmid-Burgk; D Claus; H H Kornhuber
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1982

Review 8.  Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases.

Authors:  Moussa B H Youdim
Journal:  J Neural Transm (Vienna)       Date:  2018-10-19       Impact factor: 3.575

9.  Regular moderate or intense exercise prevents depression-like behavior without change of hippocampal tryptophan content in chronically tryptophan-deficient and stressed mice.

Authors:  Hosung Lee; Makoto Ohno; Shigeo Ohta; Toshio Mikami
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.